1-3 of 3
Federica Galaverna
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antiviral potential of Vδ2 T-cells in children given TCR αβ/CD19 cell depleted HLA-haploidentical HSCT

Veronica Bordoni, Federica Guarracino, Federica Galaverna, Valentina Bertaina, Giuseppina Li Pira, Marco Rosichini, Angela Pitisci, Giulia Matusali, Fabrizio Maggi, Enrico Velardi, Pietro Merli, Franco Locatelli, Chiara Agrati
Journal: Blood Advances
Blood Adv bloodadvances.2024013902.
https://doi.org/10.1182/bloodadvances.2024013902
Published: 2024
Includes: Supplemental data
Journal Articles

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation

Clinical Trials & Observations
Elisabetta Metafuni, Irene Maria Cavattoni, Teresa Lamparelli, Anna Maria Raiola, Anna Ghiso, Federica Galaverna, Francesca Gualandi, Carmen Di Grazia, Alida Dominietto, Riccardo Varaldo, Alessio Signori, Patrizia Chiusolo, Federica Sora’, Sabrina Giammarco, Luca Laurenti, Simona Sica, Emanuele Angelucci, Andrea Bacigalupo
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2309–2318.
https://doi.org/10.1182/bloodadvances.2021005675
Published: 2022
Journal Articles

TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders

Clinical Trials & Observations
Pietro Merli, Daria Pagliara, Federica Galaverna, Giuseppina Li Pira, Marco Andreani, Giovanna Leone, Donato Amodio, Rita Maria Pinto, Alice Bertaina, Valentina Bertaina, Angela Mastronuzzi, Luisa Strocchio, Emilia Boccieri, Daniela Pende, Michela Falco, Matteo Di Nardo, Francesca Del Bufalo, Mattia Algeri, Franco Locatelli
Journal: Blood Advances
Blood Adv (2022) 6 (1): 281–292.
https://doi.org/10.1182/bloodadvances.2021005628
Published: 2022
Includes: Supplemental data